ArticleValue in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research2023

Cost-Effectiveness of Tepotinib Versus Capmatinib for the Treatment of Adult Patients With Metastatic Non-Small Cell Lung Cancer Harboring Mesenchymal-Epithelial Transition Exon 14 Skipping.

Mo Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.